Is Alzheimer's disease, relentless and slow, a better target for clinical trials?

Published Date: 16 Feb 2023

According to a report by the Alzheimer's Association task force, it's time to reframe what "clinically meaningful" means and change expectations about clinical trials.

Read Full News

Latest News

When Food Is Engineered to Be Addictive

The Milbank Quarterly finds makers used tobacco-like tactics — pairing refined carbs and fats with sensory design — to overwhelm satiety and spur compulsive eating.

How to Recognize Obsessive-Compulsive Disorder in Children

Dr Aron explains that screening tools and insight into the disorder can speed diagnosis of OCD.

The Rise of Zip-Code Immunity

With the CDC compromised by vaccine skeptics, states are being forced to build their own public health infrastructure.

When NPs and PAs Manage Cases Outside Their Specialty

Curbside consultations may take many forms, and there are significant benefits and risks involved.

NP Integration Boosts Osteoporosis Documentation

The integration of a nurse practitioner into the orthopedic inpatient workflow improves osteoporosis documentation substantially after hip fractures.

Researchers, Advocates Welcome EO on Psychedelics

The directive is expected to lead to fewer legal hurdles for psychedelic studies, increased funding, and potentially stepped-up rescheduling of the drugs.

Todays Updates

CAR-T Induces Deep, Durable Remission in Smoldering Myeloma

In a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained MRD-negative for more than 15 months. But is it a cure?

‘Bar Code’ Biopsy From RNA Could Guide Precision Oncology

New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.

Dasatinib Fails to Improve Outcomes in CBF-AML

A phase 3 study investigates the outcomes associated with intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer

A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative durvalumab and chemotherapy for NSCLC.

Measurable Residual Disease Predicts Real-World AML Relapse

A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.

Todays Updates

CAR-T Induces Deep, Durable Remission in Smoldering Myeloma

In a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained MRD-negative for more than 15 months. But is it a cure?

‘Bar Code’ Biopsy From RNA Could Guide Precision Oncology

New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.

Dasatinib Fails to Improve Outcomes in CBF-AML

A phase 3 study investigates the outcomes associated with intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer

A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative durvalumab and chemotherapy for NSCLC.

Measurable Residual Disease Predicts Real-World AML Relapse

A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.

Latest News

The Milbank Quarterly finds makers used tobacco-like tactics — pairing refined carbs and fats with sensory design — to overwhelm satiety and spur compulsive eating.

Dr Aron explains that screening tools and insight into the disorder can speed diagnosis of OCD.

With the CDC compromised by vaccine skeptics, states are being forced to build their own public health infrastructure.

Curbside consultations may take many forms, and there are significant benefits and risks involved.

The integration of a nurse practitioner into the orthopedic inpatient workflow improves osteoporosis documentation substantially after hip fractures.

The directive is expected to lead to fewer legal hurdles for psychedelic studies, increased funding, and potentially stepped-up rescheduling of the drugs.

News All Time

Suspected LGA Diagnosis May Drive Obstetric Decisions

In a study of pregnant patients, suspected large for gestational age is associated with shifts in labor management, regardless of actual fetal size.

How Male Anatomy Became Medicine’s Default and What It Means

Medical education continues to rely on male anatomy as the standard, raising concerns about diagnostic accuracy and treatment outcomes in women.

Early Emotions Shape Long-Term Mental Health in JIA

An individual's emotional state at the time of juvenile idiopathic arthritis diagnosis is linked to their future mental health outcomes.

What Precedes Aid With Dying in Young Adults With Cancer?

Researchers analyze experiences and characteristics of a cohort of adolescent and young adult patients with cancer who received medical assistance in dying in Canada.

Non-Medicinal Satiety Tips PCPs Can Suggest for Weight Loss

An emphasis on fiber and protein in food can help patients find success.

Shockwave Therapy for Erectile Dysfunction: Does It Work?

Low-intensity shockwave therapy improves erectile function in trials, but guidelines continue to classify it as investigational pending stronger long-term evidence.

Inpatient Obesity Interventions Offer Opportunities

Hospitalization may provide a wake-up call and a chance for focused interventions.

Women With SLE Show Higher Rates of Cervical HPV Infection

Women with systemic lupus erythematosus who receive immunosuppressive therapy show a higher prevalence of cervical lesions and cervical human papillomavirus infection than immunocompetent women.

Aerobic Exercise Tied to Improved Mobility, Alertness in PD

Aerobic exercise may help ease depression and daytime sleepiness in Parkinson’s disease, though its benefits for mobility, cognition, and sleep appear limited.

Episode 2: Diagnosing and Managing Cushing Syndrome

Drs Marwah Abdalla and Lewis Blevins discuss Cushing syndrome: Why it is frequently missed, how clinicians can screen for it, and how to manage it.

MASLD for Cardiologists

An overview of MASLD, including the epidemiology, diagnostic approaches, and therapeutic options highlighting the cardiologists’ role in its multidisciplinary management.

Jan 30 2026 This Week in Cardiology

Listener feedback, huge news in the rapidly expanding world of PFA AF Ablation, obesity, and a beautiful trial studying an AI-enhanced diagnostic tool in the office are the topics discussed by John Mandrola, MD, in this week’s podcast.

Exogenous Ketones and Exercise Tolerance: KETO-HFpEF

A crossover trial to determine whether ketone ester improves exercise tolerance in HFpEF.

Frailty in CVD: Time for a Universal Definition!

Citing The Death of Ivan Ilyich, the authors call for professional societies to jointly embrace a core definition of frailty for cardiovascular care and clinical practice.

Feb 06 2026 This Week in Cardiology

Problems with the PREVENT score, a breakthrough in lipid-lowering therapy, a surprising benefit in stroke care, and more thoughts on statins and preventive care of heart disease are the topics John Mandrola, MD, discusses in this week’s podcast.

Nut Consumption Linked to Improved Sperm Quality

A Spanish cross-sectional study of 222 men finds that those with the highest nut intake have higher sperm counts and 75% lower odds of abnormal motility, especially among men adhering to a Mediterranean diet.

Recommended News For You

A paper strip test might enable the early detection of cancer.

FDA Greenlights First Engineered Cell Therapy for a Solid Tumor

No Solace From Drug Scarcities; Novel Guidelines Regarding Lymphedema; A "Good" Patient Is Forgotten.

Researchers discover cellular 'doorway' exploited by cancer-causing virus

In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".

Recent Rise in Early-Onset Solid Tumors Is Associated with Accelerated Aging.

Obesity-related cancer rising among both younger and older adults worldwide, study finds

Recommended Articles For You

Interplay of Brown Hair, Follicular Biology, and Hair Growth Inhibitors in Melanoma Pathogenesis 

Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy 

Real-World Evidence and Patient Voices: Redefining Outcomes in Modern Oncology 

Understanding Epoetin and Its Role in Treating Chronic Kidney Disease  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer care crowdfunding increasingly common, but rarely successful

2.

Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC

3.

Q&A: Nipple-Sparing Mastectomy After Breast Radiation

4.

Firefighters who eat better can combat cancer.

5.

X-ray and radar technology combined to reduce cancer screening risks

1.

What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder

2.

Lu-177 Vipivotide in Prostate Cancer: A Breakthrough in Radioligand Therapy

3.

Lymphomatoid Papulosis: What You Need to Know

4.

A New Perspective on Spherocytosis: Uncovering Innovative Treatments

5.

Neoadjuvant Radiotherapy & Endocrine Therapy in ER+ Breast Cancer Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

2.

Efficient Management of First line ALK-rearranged NSCLC - Part VIII

3.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

4.

Updates on the First Line Management of ALK+ NSCLC

5.

An In-Depth Look At The Signs And Symptoms Of Lymphoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot